Overview
Reagan Bradford is an Ophthalmologist in Oklahoma City, Oklahoma. Dr. Bradford is rated as an Experienced provider by MediFind in the treatment of Nearsightedness. His top areas of expertise are Diabetic Retinopathy, Age-Related Macular Degeneration (ARMD), Late-Onset Retinal Degeneration, Endophthalmitis, and Vitrectomy. Dr. Bradford is currently accepting new patients.
His clinical research consists of co-authoring 1 peer reviewed article. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- EPO
- HMO
- PPO
- HMO
- INSURANCE PLAN
- MEDICARE MAPD
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- HMO
- PPO
- OTHER MEDICAID
- STATE MEDICAID
- EPO
- HMO
- PPO
- EPO
- HMO
- POS
- PPO
- MEDICARE DISCOUNT CARD
- MEDICARE PDP
- OTHER MEDICARE
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
608 Stanton L Young Blvd, Oklahoma City, OK 73104
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Eye Associates Of Oklahoma PLLC
Gemini Bogie is an Ophthalmologist in Oklahoma City, Oklahoma. Dr. Bogie is rated as an Advanced provider by MediFind in the treatment of Nearsightedness. Her top areas of expertise are Cataract, Glaucoma, Conjunctivitis (Pink Eye), and Neuroretinitis. Dr. Bogie is currently accepting new patients.
Kimberly M. Wise, M.D., P.C.
Meghan Saumur is an Ophthalmologist in Norman, Oklahoma. Dr. Saumur is rated as an Advanced provider by MediFind in the treatment of Nearsightedness. Her top areas of expertise are Cataract, Periorbital Cellulitis, Glaucoma, and Age-Related Macular Degeneration (ARMD). Dr. Saumur is currently accepting new patients.
Dr Thomas Wolf And Associates PLLC
Thomas Wolf is an Ophthalmologist in Edmond, Oklahoma. Dr. Wolf is rated as an Advanced provider by MediFind in the treatment of Nearsightedness. His top areas of expertise are Subconjunctival Hemorrhage, Interstitial Keratitis, Chalazion, and Ocular Hypertension (OHT). Dr. Wolf is currently accepting new patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Age-Related Macular Degeneration (ARMD)
- Diabetic RetinopathyDr. Bradford isAdvanced. Learn about Diabetic Retinopathy.
- EndophthalmitisDr. Bradford isAdvanced. Learn about Endophthalmitis.
- Late-Onset Retinal DegenerationDr. Bradford isAdvanced. Learn about Late-Onset Retinal Degeneration.
- Retinal DetachmentDr. Bradford isAdvanced. Learn about Retinal Detachment.
- Experienced
- Amaurosis FugaxDr. Bradford isExperienced. Learn about Amaurosis Fugax.
- Benign Essential BlepharospasmDr. Bradford isExperienced. Learn about Benign Essential Blepharospasm.
- CataractDr. Bradford isExperienced. Learn about Cataract.
- Cone DystrophyDr. Bradford isExperienced. Learn about Cone Dystrophy.
- Cone Rod Dystrophy Amelogenesis ImperfectaDr. Bradford isExperienced. Learn about Cone Rod Dystrophy Amelogenesis Imperfecta.
- Cone-Rod DystrophyDr. Bradford isExperienced. Learn about Cone-Rod Dystrophy.